Quercetin for Atherosclerosis
DIn vitro evidence for PCSK9 inhibition and reduced foam cell formation. Limited human data on atherosclerosis endpoints specifically.
The Bottom Line
In vitro evidence for PCSK9 inhibition and reduced foam cell formation. Limited human data on atherosclerosis endpoints specifically.
Key Statistics
2
Studies
100
Participants
Positive
Grade
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
Commonly Used Dosages
- general:
- 500-1,000 mg/day
- bloodpressuresupport:
- 500-730 mg/day
Upper limit: Not formally established; up to 1,000 mg/day used in clinical trials
Best taken: With meals; vitamin C co-supplementation may enhance bioavailability
Safety & Side Effects
Reported Side Effects
- ⚠ Generally well-tolerated
- ⚠ Headache (rare)
- ⚠ Mild gastrointestinal discomfort
- ⚠ Tingling in extremities (rare, high doses)
Known Interactions
- ● Antibiotics (quinolones — may reduce efficacy)
- ● Cyclosporine (may increase blood levels)
- ● Anticoagulants (may have mild antiplatelet effect)
- ● Blood pressure medications (additive effect)
Tolerable upper intake: Not formally established; up to 1,000 mg/day used in clinical trials
Always consult your healthcare provider before starting any supplement.
Frequently Asked Questions
Does Quercetin help with Atherosclerosis?
How much Quercetin should I take for Atherosclerosis?
Are there side effects of Quercetin?
How strong is the evidence for Quercetin and Atherosclerosis?
Related Evidence
Other ingredients for Atherosclerosis
Quercetin for other conditions
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. The products and information on this website are not intended to diagnose, treat, cure, or prevent any disease. The evidence grades presented are based on our analysis of published peer-reviewed research and do not constitute medical advice. Always consult your healthcare provider before starting any supplement regimen.